Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 699-715
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.699
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.699
Ref. | Country | Patients, n | Incidence of HCC, n (%) | Risk factors | Treatment offered |
Nakamura et al[31], 1968 | Japan | 64 | 28 (43.7) | Not provided | Details not provided |
Nakamura and Takezawa et al[32], 1982 | Japan | 13 | 6 (46.0) | Age at BCS diagnosis < 44 yr; complete obstruction of IVC | Details not provided |
Simson et al[33], 1982 | South Africa | 101 | 48 (47.5) | Not provided | Details not provided |
Rector et al[34], 1985 | United States | 10 | 2 (20.0) | Not provided | Details not provided |
Kew et al[35], 1989 | South Africa | 15 | 6 (40.0) | Not provided | Details not provided |
Okuda et al[1], 1998 | Japan | 148 | 10 (6.7) | Not provided | Details not provided |
Shrestha et al[36], 1996 | Nepal | 150 | 7 (4.6) | Not provided | Details not provided |
Bayraktar et al[24], 1998 | Turkey | 56 (prospective study duration 10 years) | 3 (5.3) | Hepatic vein thrombosis | Details not provided |
Dilawari et al[37], 1994 | India | 115 | 9 (7.8) | Not provided | Details not provided |
Matsui et al[38], 2000 | Japan | 12 | 3 (25.0) | Chronic congestion | Resection (1); TACE (1); chemotherapy (1) |
Shin et al[23], 2004 | South Korea | 73 | 15 (20.5), 6 de novo/9 follow up | Female sex not provided | TACE (11); resection (2); conservative (2) |
Moucari et al[4], 2008 | France | 97 | 11 (11.3) | Male, factor V Leiden mutation, IVC obstruction | TACE (7); LT (3); conservative (1) |
Amarapurkar et al[25], 2008 | India | 35 (prospective study); follow-up 42 mo | 1 (2.8) | Not provided | Details not provided |
Shrestha et al[39], 2009 | Nepal | 56 | 6 (10.7) | HV block | PAI (1); supportive (5) |
Gwon et al[11], 2010 | Korea | 98 | 23 (23.4) | Female sex | TACE (20); TACE + LT (3) |
Park et al[5], 2012 | Korea | 95 | 17, annual incidence 2.8 | Elevated HVPG | Intraarterial chemotherapy (3); conservative (3); LT (2) |
Liu et al[6], 2013 | China | 246 | 14 (5.6) | IVC block + stricture of hepatic venous outflow | TACE (14) |
Paul et al[9], 2015 | India | 421 | 16 (3.8) | Cirrhosis; combined IVC and HV block; long segment IVC block | TACE (11); TKI (1); conservative (4) |
Sakr et al[8], 2017 | Egypt | 348 | 15 (4.3) | Male, older age; cigarette smoking, AFP > 24.5 | TACE (4); TACE + RFA (2); TACE + TKI (1); conservative (8) |
Li et al[7], 2022 | China | 113 | 12 (10.6) | IVC block + stricture of hepatic venous outflow | Resection (2); RFA (1); Conservative (4); TACE (5) |
- Citation: Agarwal A, Biswas S, Swaroop S, Aggarwal A, Agarwal A, Jain G, Elhence A, Vaidya A, Gupte A, Mohanka R, Kumar R, Mishra AK, Gamanagatti S, Paul SB, Acharya SK, Shukla A, Shalimar. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome. World J Gastrointest Oncol 2024; 16(3): 699-715
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/699.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.699